- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- IPO Date
- Mar 5, 2021
Highlights
- Market Cap
- $75.80M
- Enterprise Value
- $295.67M
- EPS (TTM)
- -$35.27
- Total Revenue (TTM)
- $30.25M
- Gross Profit (TTM)
- $18.07M
- EBITDA (TTM)
- -$352.83M
- Year Range
- $2.62 - $21.34
- ROA (TTM)
- -110.28%
- ROE (TTM)
- 193.71%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SCLX Performance Chart
Scilex Holding Company (SCLX) is down 9.6% since the beginning of the year. At $7 per share, SCLX is trading 67.8% below its 52-week high of $21. Investors who bought $1,000 worth of SCLX shares 5 years ago would now be looking at an investment worth $32.
Loading charts...
Returns By Period
Scilex Holding Company (SCLX) has returned -9.56% so far this year and 124.71% over the past 12 months.
Scilex Holding Company
- 1D
- -8.03%
- 1M
- 80.58%
- YTD
- -9.56%
- 6M
- -22.68%
- 1Y
- 124.71%
- 3Y*
- -63.15%
- 5Y*
- -49.84%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
SCLX Monthly Returns History
Based on dividend-adjusted daily data since Mar 5, 2021, SCLX's average daily return is -0.02%, while the average monthly return is -0.38%.
Historically, 52% of months were positive and 48% were negative. The best month was Jul 2025 with a return of +127.8%, while the worst month was Nov 2022 at -56.8%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 7 months.
On a daily basis, SCLX closed higher 41% of trading days. The best single day was Apr 5, 2023 with a return of +56.6%, while the worst single day was Mar 1, 2024 at -41.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -30.16% | -3.64% | -18.88% | 57.96% | -15.40% | 23.97% | -9.56% | ||||||
| 2025 | -3.40% | -42.70% | 5.30% | -45.50% | 8.02% | 15.04% | 127.84% | 32.34% | 10.81% | -16.16% | 23.39% | -40.08% | -18.25% |
| 2024 | -19.61% | 38.41% | -29.96% | -46.34% | 26.58% | 78.70% | -17.62% | -27.67% | -19.60% | 3.86% | -32.94% | -33.79% | -79.10% |
| 2023 | 97.74% | 9.63% | -5.20% | -11.71% | -17.82% | -6.39% | -1.80% | -47.53% | -51.22% | 33.57% | -33.16% | 63.20% | -48.87% |
| 2022 | 0.50% | 0.40% | 0.49% | -0.00% | 0.29% | 0.10% | 0.78% | 0.39% | -0.10% | 0.87% | -56.80% | -11.35% | -60.26% |
| 2021 | 0.30% | 0.61% | -0.40% | 0.20% | 0.40% | 0.20% | 0.20% | 0.20% | 0.30% | -0.11% | 1.93% |
Benchmark Metrics
Scilex Holding Company has an annualized alpha of -12.09%, beta of 0.48, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since March 05, 2021.
- This stock participated in 233.76% of S&P 500 Index downside but only 15.57% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.48 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -12.09%
- Beta
- 0.48
- R²
- 0.01
- Upside Capture
- 15.57%
- Downside Capture
- 233.76%
Return for Risk
Risk / Return Rank
SCLX ranks 72 for risk / return — better than 72% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Scilex Holding Company (SCLX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SCLX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.03 | ||
| Sortino ratioReturn per unit of downside risk | -0.58 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.37 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 1.56 | 2.78 | -1.22 |
| Martin ratioReturn relative to average drawdown | 2.31 | 12.44 | -10.13 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Scilex Holding Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Scilex Holding Company was 99.23%, occurring on Apr 22, 2025. The portfolio has not yet recovered.
The current Scilex Holding Company drawdown is 97.87%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -99.23%Apr 2025 | 2y 10d | — | 3y 2moApr 2023 - now |
Bear market2022 | -72.67%Dec 2022 | 1mo 18d | 23d | 2mo 11dNov 2022 - Jan 2023 |
2023 bear market2023 | -42.23%Jan 2023 | 1d | 2mo 11d | 2mo 12dJan 2023 - Apr 2023 |
Bear market2022 | -16.08%Nov 2022 | 8d | 4d | 12dOct 2022 - Nov 2022 |
2023 pullback2023 | -8.13%Apr 2023 | 0s | 1d | 1dApr 2023 - Apr 2023 |
Drawdown Indicators
| SCLX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.23% | -56.78% | -42.45% |
Max Drawdown (1Y)Largest decline over 1 year | -80.27% | -9.10% | -71.17% |
Max Drawdown (3Y)Largest decline over 3 years | -98.20% | -18.90% | -79.30% |
Max Drawdown (5Y)Largest decline over 5 years | -99.23% | -25.43% | -73.80% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -97.87% | -1.80% | -96.07% |
Average DrawdownAverage peak-to-trough decline | -57.08% | -10.71% | -46.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 54.23% | 2.03% | +52.20% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Scilex Holding Company over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Scilex Holding Company is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for SCLX relative to other companies in the Drug Manufacturers - General industry. Currently, SCLX has a P/S ratio of 2.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SCLX
Add Scilex Holding Company to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SCLX